304 related articles for article (PubMed ID: 2517540)
1. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.
Francis MD; Hovancik K; Boyce RW
Int J Tissue React; 1989; 11(5):239-52. PubMed ID: 2517540
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis.
Campagnuolo G; Bolon B; Feige U
Arthritis Rheum; 2002 Jul; 46(7):1926-36. PubMed ID: 12124878
[TBL] [Abstract][Full Text] [Related]
3. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.
Mirshafiey A; Cuzzocrea S; Rehm B; Mazzon E; Saadat F; Sotoude M
Scand J Immunol; 2005 May; 61(5):435-41. PubMed ID: 15882435
[TBL] [Abstract][Full Text] [Related]
6. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
Smith RJ; Sly LM
J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
[TBL] [Abstract][Full Text] [Related]
7. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the rat.
Helyes Z; Szabó A; Németh J; Jakab B; Pintér E; Bánvölgyi A; Kereskai L; Kéri G; Szolcsányi J
Arthritis Rheum; 2004 May; 50(5):1677-85. PubMed ID: 15146439
[TBL] [Abstract][Full Text] [Related]
9. Bone protective effect of simvastatin in experimental arthritis.
Funk JL; Chen J; Downey KJ; Clark RA
J Rheumatol; 2008 Jun; 35(6):1083-91. PubMed ID: 18464303
[TBL] [Abstract][Full Text] [Related]
10. Effects and mechanisms of total glucosides of paeony on joint damage in rat collagen-induced arthritis.
Zhu L; Wei W; Zheng YQ; Jia XY
Inflamm Res; 2005 May; 54(5):211-20. PubMed ID: 15953993
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis.
Badger AM; Blake S; Kapadia R; Sarkar S; Levin J; Swift BA; Hoffman SJ; Stroup GB; Miller WH; Gowen M; Lark MW
Arthritis Rheum; 2001 Jan; 44(1):128-37. PubMed ID: 11212150
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
13. Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis.
Badger AM; Blake SM; Dodds RA; Griswold DE; Swift BA; Rieman DJ; Stroup GB; Hoffman SJ; Gowen M
J Pharmacol Exp Ther; 1999 Dec; 291(3):1380-6. PubMed ID: 10565864
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
15. Effects of Yunke (technetium-99 conjugated with methylene diphosphonate; (99)Tc-MDP) and/or colloidal chromic phosphate phosphonium-32, alone and in combination, in rats with adjuvant arthritis.
Wang L; Gu Q; Xu Y; Li S; Gui J; Yang J; Yao Q; Ji Y
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):23-8. PubMed ID: 18047623
[TBL] [Abstract][Full Text] [Related]
16. Effects of bisphosphonates on joint damage and bone loss in rat adjuvant-induced arthritis.
Harada H; Nakayama T; Nanaka T; Katsumata T
Inflamm Res; 2004 Feb; 53(2):45-52. PubMed ID: 15021968
[TBL] [Abstract][Full Text] [Related]
17. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Paola RD; Genovese T; Muià C; Caputi AP; Salvemini D
Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059
[TBL] [Abstract][Full Text] [Related]
18. Treatment of rat adjuvant arthritis with flavonoid (Detralex), methotrexate, and their combination.
Rovenský J; Stancíková M; Rovenská E; Stvrtina S; Stvrtinová V; Svík K
Ann N Y Acad Sci; 2009 Sep; 1173():798-804. PubMed ID: 19758231
[TBL] [Abstract][Full Text] [Related]
19. Dual effect of nitric oxide donor on adjuvant arthritis.
Gomaa AA; Elshenawy MM; Afifi NA; Mohammed EA; Thabit RH
Int Immunopharmacol; 2009 Apr; 9(4):439-47. PubMed ID: 19193354
[TBL] [Abstract][Full Text] [Related]
20. Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis.
Osterman T; Virtamo T; Laurén L; Kippo K; Pasanen I; Hannuniemi R; Väänänen K; Sellman R
J Pharmacol Exp Ther; 1997 Feb; 280(2):1001-7. PubMed ID: 9023317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
